Favoritism at its best - It is all about the data quantity and not data quality
Pros
The company has awesome Velocigene technology and has a capability to generate next generation therapeutics. The science responsible for Regeneron's success as a biotech company
Cons
It is all about the quantity and not quality: To support the pace of Regeneron’s drug discovery workflow, lot of senior scientists just want to generate the data without worrying about the quality. They don’t want to take some extra time to optimize experimental conditions and disregard the importance of careful design of experiment (DOE). Most of the senior members have been with the company for more than 16 years and are very proud of Regeneron's discovery strategy. Although I respect their pride; especially since it backs up with the company’s growth; lot of time they get egocentric; disregarding any new ideas produced by young scientists. Moreover, the senior members also have their own favorites; mostly people working with them since the beginning of their career which is very disheartening for younger scientists. I understand that everyone has their favorites; but please don’t make it obvious. Regeneron 5; the company’s core values is losing its value and lot of people including myself feel like working for the pay check and not for science. Stock options; the main reason for people wanting to work for Regeneron, is not an incentive anymore; especially due to the dropping stock value. So lot of employees, including myself wants to change the job for a better work culture and a better work-life balance.